$CTY SEC Filings

Filed On	Filing
26 Oct 2026	SCHEDULE 13D
26 Oct 2026	SCHEDULE 13G
22 Oct 2026	SCHEDULE 13G
19 Oct 2026	Form 4: Arch Venture Partners XII, Llc, 10% owner and 5 others Received 10,804,215 shares by conversion · Bought 170,000 shares ($3.06M)
19 Oct 2026	Form 4: Nelsen Robert, Director Granted 22,649 Stock Option (Right to Buy) · Received 10,804,215 shares by conversion · Bought 170,000 shares ($3.06M)
19 Oct 2026	Form 4: Maraganore John, Director Granted 22,649 Stock Option (Right to Buy) · Received 610,759 shares by conversion
19 Oct 2026	Form 4: Nochur Sara, Director Granted 22,649 Stock Option (Right to Buy)
19 Oct 2026	Form 4: Orth Andrew C., Director Granted 77,979 Stock Option (Right to Buy)
19 Oct 2026	Form 4: Philip Ron M, Director Granted 22,649 Stock Option (Right to Buy)
19 Oct 2026	Form 4: Greene Barry E, Director Granted 22,649 Stock Option (Right to Buy)
19 Oct 2026	8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Section 1. Annual Meeting. The annual meeting of stockholders (any such meeting being referred to in these Bylaws as an “Annual Meeting”) shall be held at the hour, date and place within or without the United States that is fixed by or i...
16 Oct 2026	424B4
16 Oct 2026	FORM S-8
15 Oct 2026	EFFECT
15 Oct 2026	Form 3: Arch Venture Partners XII, Llc, 10% owner and 5 others Holds 2,718,292 shares of Common Stock
15 Oct 2026	Form 3: Zimmermann Tracy, Chief Scientific Officer
15 Oct 2026	Form 3: Trousil Sebastian, Chief Operating Officer Holds 534,511 shares of Common Stock
15 Oct 2026	Form 3: Regnante Keith, Chief Financial Officer
15 Oct 2026	Form 3: Philip Ron M, Director
15 Oct 2026	Form 3: Orth Andrew C., Director Holds 1,063,154 shares of Common Stock

Comments